Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA/CMS Discussing Liaison Office To Improve Coverage Decisions

Executive Summary

FDA is considering the creation of a liaison office to provide guidance to the Centers for Medicare & Medicaid Services on federal coverage decisions for new products

You may also be interested in...



Generic Biologics Are Coming, Commissioner McClellan Tells MBC

Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council

Generic Biologics Are Coming, Commissioner McClellan Tells MBC

Biogen is understood to be drafting a position statement on generic biologics on behalf of the Massachusetts Biotechnology Council

FDA, CMS Coordination On Coverage Decisions May Improve Under McClellan

FDA and the Centers for Medicare & Medicaid Services are likely to have a closer relationship under incoming Commissioner McClellan

UsernamePublicRestriction

Register

PS040944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel